SavedAdd your journal

Journals / Batı Karadeniz Tıp Dergisi / 2026 / Cilt: 4 Sayı: 1

Report of Familial Mediterranean Fever with Repeating Localized Rash and Weakness

Tekrarlayan Lokalize Döküntü ve Halsizlikle Başvuran Ailesel Akdeniz Ateşi Olgu Sunumu

Coşkun Ekemen(ZONGULDAK KARADENİZ EREĞLİ DEVLET HASTANESİ)0000-0002-1957-9855
Ahmet Girgeç(BÜLENT ECEVİT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-0373-9615
Hakan Kardeş(BÜLENT ECEVİT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-0553-7072
Zühal Örnek(BÜLENT ECEVİT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-9252-1652
Pages
34–37
Publication Date
2020-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this way, early amyloidosis development and complications due to FMF will be prevented in children

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Familial Mediterranean Fever (FMF), which is inherited as autosomal recessive, is characterized by recurrent fever, rash, arthritis, arthralgia, and abdominal pain.
📊
Key Findings & Data:The most important complication of FMF, which can affect many systems, is amyloidosis development due to kidney involvement.
💡
Conclusion & Impact:In this way, early amyloidosis development and complications due to FMF will be prevented in children
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:FMF · ailesel akdeniz ateşi · artrit

Abstract

Familial Mediterranean Fever (FMF), which is inherited as autosomal recessive, is characterized by recurrent fever, rash, arthritis, arthralgia, and abdominal pain. The most important complication of FMF, which can affect many systems, is amyloidosis development due to kidney involvement. The main drug used in the treatment is colchicine. In this article, a case which arrived at the pediatric clinic with recurrent unilateral localized ankle complaints of edema, erythema together with rash and which, as a result of clinical and genetic tests, was diagnosed as FMF is examined. Symptoms observed at the preliminary diagnosis such as recurrent fever, abdominal pain, arthritis or arthralgia or isolated erysipelas should definitely remind pediatricians FMF. In this way, early amyloidosis development and complications due to FMF will be prevented in children

Özet

Otozomal resesif kalıtılan Ailesel Akdeniz Ateşi tekrarlayan ateş, döküntü, artrit, artralji, karın ağrısı gibi klinik bulgularla karakterizedir. Birçok sistemi tutabilen FMF’nin en önemli komplikasyonu böbrek tutulumuna bağlı amiloidoz gelişimidir. Tedavide kullanılan temel ilaç ise kolşisindir. Bu makalede çocuk hastalıkları polikliniğine tekrarlayan tek taraflı lokalize ayak bileğinde ödem, kızarıklık ve döküntü yakınmaları ile başvuran ve takibinde klinik ve genetik tetkikler sonucunda FMF tanısı alan bir olgu sunulmuştur. Tekrarlayan ateş, karın ağrısı, artrit veya artralji ya da izole erizipel benzeri döküntüsü olan çocuklarda FMF ön tanıda mutlaka akla gelmelidir. Bu sayede çocuklarda erken amiloidoz gelişimi ve FMF’e bağlı komplikasyonlar da engellenmiş olacaktır

🔖

Cite This Article

Ekemen, C., Girgeç, A., Kardeş, H., Örnek, Z. (2020). Report of Familial Mediterranean Fever with Repeating Localized Rash and Weakness. Batı Karadeniz Tıp Dergisi, Cilt: 4 Sayı: 1, 34–37. https://ajindex.com/articles/1374513

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. Önen F. Ailevi Akdeniz ateşi. Rheumatol Int. 2006; 26: 489–96
  2. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972;287:1302.
  3. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53
  4. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
  5. Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009;61:1447–53.
  6. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine(Baltimore) 1998;77(4):268–97.
  7. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005;84:1–11.
  8. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416–9.
  9. Jarjour RA, Dodaki R. Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep. 2011;38:2033–6.
  10. Ince E, Cakar N, Tekin M, Kendirli T, Ozkaya N, Akar N, et al. Arthritis in children with familial Mediterranean fever. Rheumatol Int. 2002;21:213–7.
  11. Üzüm Ö ve ark., Familial Mediterranean fever and prolonged febrile myalgia syndrome: Case report, İzmir Dr. Behçet Uz Çocuk Hast. Dergisi 2017; 7(2):164-166
  12. Ceylan Ö, Ceylan Y. Intermittent right bundle branch block in a child with familial mediterranean fever. Cardiol J. 2018;25(6):753-755.
  13. Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopatho logic correlation. J Am Acad Dermatol. 2000;42:791–5.
  14. Petty RE, Cassidy JT. Textbook of pediatric rheumatology.Philadelphia: Saunders Elsevier; 2011
  15. Lidar M, Doron A, Barzilai A, vd. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever J Eur Acad DermatolVenereol 2013; 27: 912.
  16. Keskindemirci G ve ark. Çocuklarda Lenfadenopatinin Nadir Bir Nedeni: Otoinflamatuvar Hastalık - Ailevi Akdeniz Ateşi, Turkish J Pediatr Dis,2016; 4: 274-276
  17. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol. 1998;27:92–7.
  18. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974;291:934–7.
  19. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med.1974;291:9324.
  20. Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med. 1974;81:792–4.
  21. Erken E, Ozer HT, Bozkurt B, Gunesacar R, Erken EG, Dinkci S. Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion. Joint Bone Spine. 2008;75:370–2.
  22. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum. 2011;41:265–71.
  23. Önen F. Ailevi Akdeniz ateşi. Rheumatol Int. 2006; 26: 489–96
  24. Keskindemirci G ve ark. Çocuklarda Lenfadenopatinin Nadir Bir Nedeni: Otoinflamatuvar Hastalık - Ailevi Akdeniz Ateşi, Turkish J Pediatr Dis,2016; 4: 274-276